Tegaserod Maleate INTERACTION, CAS number 189188-57-6, Molecular Formula C16H23N5O, exporter,products,buyers in India

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Tegaserod Maleate Manufacturers in India Suppliers Tegaserod Maleate Exporters Distributors Tegaserod Maleate api active pharmaceuticals ingredients Tegaserod Maleate manufacturers Side Effects bulk drugs raw material Tegaserod Maleate companies Side Effects Importers Tegaserod Maleate Tegaserod Maleate Exporters Tegaserod Maleate exporters FDA Tegaserod Maleate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Tegaserod Maleate manufacturing pharmaceutical drugs pharmaceutical intermediates Tegaserod Maleate pharmaceutical chemicals pharmaceutical raw materials Tegaserod Maleate active pharmaceutical ingredients Tegaserod Maleate committee active pharmaceutical ingredients manufacturer Tegaserod Maleate Active Pharmaceutical Ingredients manufacturer Tegaserod Maleate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Tegaserod Maleate, Tegaserod Maleate manufacturer India, Tegaserod Maleate product, Tegaserod Maleate products, Api preparation, Certificate of Analysis API manufacturer product, Tegaserod Maleate anti ulcer product, Certificate of Origin COA Tegaserod Maleate COS Tegaserod Maleate, pharmaceutical generic, pharmaceutical drug, medical, Tegaserod Maleate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Tegaserod Maleate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Tegaserod Maleate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Tegaserod Maleate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Tegaserod Maleate ingredients, api, HIV Tegaserod Maleate, tablets, capsules, syrup & protein Tegaserod Maleate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Tegaserod Maleate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Tegaserod Maleate WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API
	Pharmaceuticals API List >>
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

HOME >> Pharmaceuticals API List 3 >> Tegaserod Maleate >> Interaction

INTERACTION

Tegaserod Maleate

CAS number 189188-57-6

Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with them first.

Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use.

Keep a list of all your medications with you, and share the list with your doctor.

Dextromethorphan

A pharmacokinetic interaction study demonstrated that co-administration of tegaserod and dextromethorphan did not change the pharmacokinetics of either compound to a clinically relevant extent. Dose adjustment of either drug is not necessary when tegaserod is combined with dextromethorphan. Therefore, tegaserod is not expected to alter the pharmacokinetics of drugs metabolized by CYP2D6 (e.g., fluoxetine, omeprazole, captopril).

Theophylline

A pharmacokinetic interaction study demonstrated that co-administration of tegaserod and theophylline did not affect the pharmacokinetics of theophylline. Dose adjustment of theophylline is not necessary when tegaserod is co-administered. Therefore, tegaserod is not expected to alter the pharmacokinetics of drugs metabolized by CYP1A2 (e.g., estradiol, omeprazole).

Digoxin

A pharmacokinetic interaction study with digoxin demonstrated that concomitant administration of tegaserod reduced peak plasma concentration and exposure of digoxin by approximately 15%. This reduction of bioavailability is not considered clinically relevant. When tegaserod is co-administered with digoxin dose adjustment is unlikely to be required.

Warfarin

A pharmacokinetic and pharmacodynamic interaction study with warfarin demonstrated no effect of concomitant administration of tegaserod on warfarin pharmacokinetics and pharmacodynamics. Dose adjustment of warfarin is not necessary when tegaserod is co-administered.

Information Associated with Product:

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION >>

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

More Api at Taj Pharmaceuticals Ltd.

Quetiapine Fumarate	Quinine Sulfate	Rabeprazole Sodium	Ramipril	Ranitidine Hydrochloride	Risperidone	Rivastigmine Tartrate	Rizatriptan	Rosiglitazone Maleate	Telmisartan	Tamsulosin HCl
Tegaserod Maleate	Terbinafine HCl	Tolterodine Tartrate	Trandolapril	Valdecoxib	Valsartan	Venlafaxine	Voriconazole	Zolmitriptan	Zonisamide	Primidone

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.